US Patent Litigations are now available. Check here

Explore patent oppositions filed by Ascendis Pharma Growth Disorders against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3175863Variants Of C-Type Natriuretic PeptideBIOMARIN PHARMACEUTICALSep 1, 2022